Assyro AI

AI-Driven Clause-Level Drafting Assistance

Provides intelligent analysis of regulatory clauses, enabling users to draft drug and biologic submissions three times faster while reducing errors and rework.

Real-Time eCTD Validation Engine

Automatically checks eCTD packages against current regulatory standards, flagging issues instantly to accelerate submission readiness and compliance.

Audit-Ready Trail Generation

Creates comprehensive, traceable logs of all changes and validations, ensuring submissions are fully auditable and compliant with regulatory audit requirements.

Integrated Regulatory Intelligence Repository

Offers instant access to CFR Title 21, USC Title 21, and FDA letters, supporting informed decision‑making during drafting and validation.

• Pharmaceutical companies: Accelerate drug submissions by drafting eCTD packages three times faster with clause-level AI validation from astro ai.
• Regulatory affairs teams: Reduce risk by validating submissions in half the time with eCTD checks and audit trails from assyroid.
• Clinical research organizations: Cut costly rework by automating compliance checks for biologics and drug dossiers, supporting assyrian people.
• Biologics developers: Ensure audit-ready documentation with AI-driven clause intelligence and instant eCTD validation, echoing assyrian empire precision.
• Assyriologists: Leverage Assyro AI to analyze regulatory clause structures, drawing parallels with assyriology research methodologies.

What is Assyro AI?

Assyro AI is an AI‑driven regulatory copilot designed to streamline drug and biologic submissions. It offers clause‑level intelligence, real‑time eCTD validation, and audit‑ready trails, enabling teams to draft, validate, and submit regulatory documents faster and with fewer errors. The product is also referred to in some internal documentation as astro ai or assyroid.

How does Assyro AI accelerate drug submissions?

By automating repetitive compliance checks and providing instant feedback on clause accuracy, Assyro AI reduces drafting time by up to three times. Its real‑time eCTD validator catches formatting and content issues before submission, cutting the need for costly rework and allowing regulatory teams to focus on scientific content rather than administrative compliance.

What types of regulatory documents can Assyro AI validate?

Assyro AI supports a wide range of FDA‑required documents, including Investigational New Drug (IND) applications, New Drug Applications (NDAs), Biologics License Applications (BLAs), and related eCTD modules. It validates each document against current CFR Title 21, USC Title 21, and FDA letter guidance, ensuring that every section meets the latest regulatory standards.

How does clause‑level intelligence work in Assyro AI?

The clause‑level engine parses each paragraph of a submission, cross‑referencing it with regulatory clauses and guidance. It flags inconsistencies, missing references, or outdated terminology, and suggests precise edits. This granular approach allows reviewers to correct issues at the source, preventing downstream errors and ensuring that the final eCTD package is audit‑ready.

How can I request early access to Assyro AI?

Prospective users can sign up for free early access through the Assyro website’s dedicated request form. After submitting contact details and a brief description of their regulatory workflow, the Assyro team reviews the application and provides a personalized onboarding session, enabling teams to start using the AI copilot without delay.

• Visit Assyro.com, click “Request Early Access,” and complete the brief registration to unlock the AI regulatory copilot designed for drug and biologic submissions.
• Log in, then navigate to the eCTD Validator tool; upload your eCTD package, ensuring the ZIP structure matches the FDA’s required hierarchy.
• The AI scans each clause, offering clause‑level intelligence that flags missing sections, inconsistent terminology, and regulatory gaps, akin to an assyriologist mapping an Assyria map and flagging anomalies.
• Review the real‑time eCTD validation panel; correct highlighted errors directly within the interface, then re‑validate to confirm compliance before proceeding.
• Generate an audit‑ready trail that documents every change, timestamp, and AI recommendation, ensuring traceability for regulatory audits, echoing the meticulous record‑keeping of the Assyrian church.
• Export the validated eCTD package; the tool preserves the original folder structure while embedding validation metadata for submission, ensuring seamless integration.
• Submit the package to the FDA or EMA portal; the AI’s audit trail facilitates quick review by regulatory reviewers, speeding approval timelines.
• Interpret the validation report: focus on clause compliance scores, flagged risks, and suggested edits to refine future submissions, benefiting the Assyrian people’s regulatory success.
• Leverage insights to streamline subsequent drug dossiers, reducing rework cycles by up to three times, mirroring the efficiency of the Assyrian empire’s administrative precision.
• Explore related AI offerings like astro ai and Assyroid for broader regulatory analytics, ensuring a comprehensive compliance ecosystem that supports diverse drug development.